
Par Drugs and Chemicals Ltd
NSE:PAR

Fundamental Analysis


Revenue & Expenses Breakdown
Par Drugs and Chemicals Ltd
Balance Sheet Decomposition
Par Drugs and Chemicals Ltd
Current Assets | 540.5m |
Cash & Short-Term Investments | 298.5m |
Receivables | 193.7m |
Other Current Assets | 48.3m |
Non-Current Assets | 416.1m |
Long-Term Investments | 100k |
PP&E | 409.7m |
Other Non-Current Assets | 6.3m |
Free Cash Flow Analysis
Par Drugs and Chemicals Ltd
INR | |
Free Cash Flow | INR |
Earnings Waterfall
Par Drugs and Chemicals Ltd
Revenue
|
973.1m
INR
|
Cost of Revenue
|
-353.7m
INR
|
Gross Profit
|
619.4m
INR
|
Operating Expenses
|
-432.3m
INR
|
Operating Income
|
187.1m
INR
|
Other Expenses
|
-44.9m
INR
|
Net Income
|
142.3m
INR
|
PAR Profitability Score
Profitability Due Diligence
Par Drugs and Chemicals Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

Score
Par Drugs and Chemicals Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
PAR Solvency Score
Solvency Due Diligence
Par Drugs and Chemicals Ltd's solvency score is 93/100. The higher the solvency score, the more solvent the company is.

Score
Par Drugs and Chemicals Ltd's solvency score is 93/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PAR Price Targets Summary
Par Drugs and Chemicals Ltd
Dividends
Current shareholder yield for PAR is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?